# 8-K filed: Neumora Therapeutics, Inc.

> sec 8k · VERIFIED · 2026-06-15

<b>Filed:</b> 2026-06-15 <b>AccNo:</b> 0001193125-26-270328 <b>Size:</b> 185 KB
<br>Item 1.01: Entry into a Material Definitive Agreement
<br>Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
<br>Item 2.05: Cost Associated with Exit or Disposal Activities
<br>Item 7.01: Regulation FD Disclosure
<br>Item 8.01: Other Events
<br>Item 9.01: Financial Statements and Exhibits

- Company: Neumora Therapeutics, Inc.
- Sector: biotech
- Primary source: https://www.sec.gov/Archives/edgar/data/1885522/000119312526270328/0001193125-26-270328-index.htm

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.